Semi-Annual Statement Of Income

Carna Biosciences, Inc. - Filing #7586726

Concept 2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2021-01-01 to
2021-09-30
2021-01-01 to
2021-09-30
2021-01-01 to
2021-09-30
Semi-annual statement of income
Statement of income
Net sales
809,562,000 JPY
286,045,000 JPY
1,095,607,000 JPY
636,512,000 JPY
636,512,000 JPY
JPY
Cost of sales
123,674,000 JPY
95,794,000 JPY
Ordinary profit (loss)
-735,543,000 JPY
-1,171,814,000 JPY
Gross profit (loss)
971,932,000 JPY
540,717,000 JPY
Selling, general and administrative expenses
1,725,638,000 JPY
1,709,734,000 JPY
Extraordinary losses
43,062,000 JPY
6,108,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
-778,606,000 JPY
-1,177,923,000 JPY
Operating profit (loss)
335,507,000 JPY
-1,089,213,000 JPY
-753,705,000 JPY
-1,169,016,000 JPY
199,283,000 JPY
-1,368,300,000 JPY
Income taxes - current
16,703,000 JPY
5,924,000 JPY
Non-operating income
24,660,000 JPY
10,345,000 JPY
Non-operating income
Interest income
127,000 JPY
90,000 JPY
Dividend income
307,000 JPY
298,000 JPY
Income taxes - deferred
-91,000 JPY
-5,772,000 JPY
Non-operating expenses
6,498,000 JPY
13,143,000 JPY
Income taxes
16,612,000 JPY
151,000 JPY
Non-operating expenses
Interest expenses
4,278,000 JPY
3,081,000 JPY
Profit (loss)
-795,218,000 JPY
-1,178,075,000 JPY
Extraordinary losses
Impairment losses
43,062,000 JPY
6,108,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.